Cargando…
Skin cytokine expression in patients with fibromyalgia syndrome is not different from controls
BACKGROUND: Fibromyalgia syndrome (FMS) is a chronic pain syndrome of unknown etiology. There is increasing evidence for small nerve fiber impairment in a subgroup of patients with FMS. We investigated whether skin cytokine and delta opioid receptor (DOR) gene expression in FMS patients differs from...
Autores principales: | Üçeyler, Nurcan, Kewenig, Susanne, Kafke, Waldemar, Kittel-Schneider, Sarah, Sommer, Claudia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4175620/ https://www.ncbi.nlm.nih.gov/pubmed/25240423 http://dx.doi.org/10.1186/s12883-014-0185-0 |
Ejemplares similares
-
Increased cortical activation upon painful stimulation in fibromyalgia syndrome
por: Üçeyler, Nurcan, et al.
Publicado: (2015) -
Local and Systemic Cytokine Expression in Patients with Postherpetic Neuralgia
por: Üçeyler, Nurcan, et al.
Publicado: (2014) -
Systematic review with meta-analysis: cytokines in fibromyalgia syndrome
por: Üçeyler, Nurcan, et al.
Publicado: (2011) -
Cortical Binding Potential of Opioid Receptors in Patients With Fibromyalgia Syndrome and Reduced Systemic Interleukin-4 Levels – A Pilot Study
por: Üçeyler, Nurcan, et al.
Publicado: (2020) -
Characterization of dermal skin innervation in fibromyalgia syndrome
por: Evdokimov, Dimitar, et al.
Publicado: (2020)